States join antitrust suit against ‘pharma bro’ Shkreli

Six state attorneys have joined a suit filed against incarcerated ‘pharma bro’ Martin Shkreli and his company Vyera Pharmaceuticals for allegedly monopolising the market for a life-saving drug.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

States join antitrust suit against ‘pharma bro’ Shkreli

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features